Shares of CASI Pharmaceuticals Inc. (CASI) surged 40% to $4.99 in premarket trading today, in response to a preliminary non-binding offer to purchase the company's entire China-based operations.
On June 21, 2024, Dr. Wei-Wu He, Chairman of the Board and CEO, submitted a proposal to acquire the entire business operations of the company in China, along with all license-in, distribution, and related rights in Asia (excluding Japan) for its pipeline products.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.